Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Morris, Michael J.
Larson, Steven M.
Helgstrand, John T.
Oturai, Peter S.
Røder, Martin Andreas
Funding for this research was provided by:
Medicinska Forskningsrådet (D0484201)
Governmental funding of clinical research within the National Health Services in Sweden (ALFSKANE 440281)
unspecified valid from 2016-03-09